Viewing Study NCT00261495


Ignite Creation Date: 2025-12-24 @ 2:10 PM
Ignite Modification Date: 2026-01-28 @ 8:08 AM
Study NCT ID: NCT00261495
Status: COMPLETED
Last Update Posted: 2014-06-03
First Post: 2005-12-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of the Effectiveness and Safety of Sustained-release Hydromorphone (a Strong Opioid) in Patients With Chronic Noncancer Pain.
Sponsor: Janssen Pharmaceutica N.V., Belgium
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CR002374
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators